Gennaro M Lenato
Overview
Explore the profile of Gennaro M Lenato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
224
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dupuis-Girod S, Shovlin C, Kjeldsen A, Mager H, Sabba C, Droege F, et al.
Eur J Med Genet
. 2022 Aug;
65(10):104575.
PMID: 35940549
Hereditary haemorrhagic telangiectasia (HHT) is a rare vascular multisystemic disease that leads to epistaxis, anaemia due to blood loss, and arteriovenous malformations (AVMs) in organs such as the lungs, liver...
2.
Custodero C, Ciavarella A, Panza F, Gnocchi D, Lenato G, Lee J, et al.
Geroscience
. 2022 Apr;
44(3):1373-1392.
PMID: 35486344
Vascular contribution to cognitive impairment and dementia (VCID) is a clinical label encompassing a wide range of cognitive disorders progressing from mild to major vascular cognitive impairment (VCI), which is...
3.
Pepe M, Suppressa P, Giuliano A, Nestola P, Bortone A, De Cillis E, et al.
Minerva Cardiol Angiol
. 2021 Mar;
70(5):537-544.
PMID: 33703853
Background: Left atrial appendage (LAA) closure represents a novel therapeutic chance for patients with contraindications to long-term anticoagulation therapy, such as those affected by hereditary hemorrhagic telangiectasia (HHT) and atrial...
4.
Eker O, Boccardi E, Sure U, Patel M, Alicante S, Alsafi A, et al.
Orphanet J Rare Dis
. 2020 Jul;
15(1):165.
PMID: 32600364
Hereditary haemorrhagic telangiectasia (HHT) is a multisystemic vascular dysplasia inherited as an autosomal dominant trait. Approximately 10 % of patients have cerebral vascular malformations, a proportion being cerebral arteriovenous malformations...
5.
Giordano P, Francavilla M, Buonamico P, Suppressa P, Lastella P, Sangerardi M, et al.
Vasa
. 2017 Mar;
46(3):195-202.
PMID: 28248153
Background: Liver involvement is a common manifestation of hereditary haemorrhagic telangiectasia (HHT). Although a number of studies have been carried out in adult patients, no study has ever been focused...
6.
Giordano P, Sangerardi M, Suppressa P, Lastella P, Attolini E, Valente F, et al.
J Pediatr Hematol Oncol
. 2014 Sep;
37(3):e200-3.
PMID: 25222056
Background: A 17-year-old boy was referred to our center with a history of brain abscess (BA) recurring after 9 years. The patient reported 2 previous treatments for pulmonary arteriovenous malformations,...
7.
Giordano P, Lenato G, Suppressa P, Lastella P, Dicuonzo F, Chiumarulo L, et al.
J Pediatr
. 2013 Mar;
163(1):179-86.e1-3.
PMID: 23535011
Objective: To evaluate the clinical features in a large cohort of pediatric patients with genetically confirmed hereditary hemorrhagic telangiectasia (HHT) and to identify possible predictors of arteriovenous malformation (AVM) onset...
8.
Pierucci P, Lenato G, Suppressa P, Lastella P, Triggiani V, Valerio R, et al.
Orphanet J Rare Dis
. 2012 Jun;
7:33.
PMID: 22676497
Background: The difficulty in establishing a timely correct diagnosis is a relevant matter of concern for several rare diseases. Many rare-disease-affected patients suffer from considerable diagnostic delay, mainly due to...
9.
Candelli M, Pompili M, Suppressa P, Lenato G, Bosco G, Rapaccini G, et al.
Intern Emerg Med
. 2011 Feb;
7(4):323-9.
PMID: 21305365
Hepatic arteriovenous malformations (HAVMs) in hereditary hemorrhagic telangiectasia (HHT) have long been considered to have scarce clinical significance in most cases. Nevertheless, data are lacking regarding the influence of HAVMs...
10.
Giordano P, Lenato G, Pierucci P, Suppressa P, Altomare M, Del Vecchio G, et al.
J Pediatr Hematol Oncol
. 2009 Jul;
31(8):577-82.
PMID: 19636272
The purpose of this study was to estimate vascular endothelial growth factor (VEGF) and transforming growth factor (TGF)-beta1 serum levels in children with hereditary hemorrhagic telangiectasia (HHT) type 1 and...